Daito Pharmaceutical Co.,Ltd.

TSE:4577 Stok Raporu

Piyasa değeri: JP¥34.0b

Daito PharmaceuticalLtd Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Daito PharmaceuticalLtd is forecast to grow earnings and revenue by 8.8% and 7.1% per annum respectively. EPS is expected to grow by 10.1% per annum. Return on equity is forecast to be 5.6% in 3 years.

Anahtar bilgiler

8.8%

Kazanç büyüme oranı

10.1%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi11.9%
Gelir büyüme oranı7.1%
Gelecekteki özkaynak getirisi5.6%
Analist kapsamı

Low

Son güncelleme23 Jul 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 19
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Kazanç ve Gelir Büyüme Tahminleri

TSE:4577 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (JPY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
5/31/202757,5003,8703,570N/A1
5/31/202653,0003,3002,400N/A1
5/31/202549,5002,710310N/A1
8/31/202447,3953,230N/AN/AN/A
5/31/202446,8953,295-1,0945,182N/A
2/29/202445,1933,279N/AN/AN/A
11/30/202345,8443,390-2,6894,960N/A
8/31/202345,2383,337N/AN/AN/A
5/31/202345,1013,600-1,4014,155N/A
2/28/202344,4513,350N/AN/AN/A
11/30/202244,3683,653-1,6193,104N/A
8/31/202243,7593,789N/AN/AN/A
5/31/202243,4644,668-3634,370N/A
2/28/202244,4624,525N/AN/AN/A
11/30/202145,1424,6002215,870N/A
8/31/202146,7574,750N/AN/AN/A
5/31/202148,7144,246-1,1675,182N/A
2/28/202148,4544,402N/AN/AN/A
11/30/202047,7734,365-5433,455N/A
8/31/202047,0364,345N/AN/AN/A
5/31/202044,9913,9441,5334,306N/A
2/29/202045,1054,204N/AN/AN/A
11/30/201944,2423,8424,5207,481N/A
8/31/201943,0533,654N/AN/AN/A
5/31/201941,1343,5133,2266,888N/A
2/28/201940,6403,291N/AN/AN/A
11/30/201839,5663,1272,2155,829N/A
8/31/201839,9333,147N/AN/AN/A
5/31/201839,8753,041N/A5,465N/A
2/28/201839,7012,913N/AN/AN/A
11/30/201739,2192,820N/A4,539N/A
8/31/201738,5542,658N/AN/AN/A
5/31/201737,9842,656N/A5,069N/A
2/28/201737,2832,698N/AN/AN/A
11/30/201637,2702,722N/A3,385N/A
8/31/201636,7472,559N/AN/AN/A
5/31/201636,3702,566N/A2,948N/A
2/29/201636,4162,639N/AN/AN/A
11/30/201535,6912,403N/A3,252N/A
8/31/201535,3702,468N/AN/AN/A
5/31/201534,0582,246N/A3,739N/A
2/28/201533,7652,080N/AN/AN/A
11/30/201432,5282,010N/A3,709N/A
8/31/201431,5601,864N/AN/AN/A
5/31/201431,1961,811N/A2,744N/A
2/28/201429,8761,910N/AN/AN/A
11/30/201329,6801,787N/A2,990N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4577's forecast earnings growth (8.8% per year) is above the savings rate (0.3%).

Kazançlar ve Piyasa: 4577's earnings (8.8% per year) are forecast to grow slower than the JP market (8.9% per year).

Yüksek Büyüme Kazançları: 4577's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: 4577's revenue (7.1% per year) is forecast to grow faster than the JP market (4.2% per year).

Yüksek Büyüme Geliri: 4577's revenue (7.1% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4577's Return on Equity is forecast to be low in 3 years time (5.6%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y